Kathryn E. Ware

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer”.

A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0454

N/A

0DataRank · unranked

38 citations

Roham Salman Roghani, Ali Sanjari Moghaddam, Beatrice C. Thomas, Gabrielle Rupprecht, Kathryn E. Ware +8 more

Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.22.050385

N/A

0DataRank · unranked

14 citations

Santosh Gupta, Jared Eng, Gabor Kemeny, Bhairavy Puviindran, Wen‐Chi Foo +18 more

Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry

Prostate Cancer and Prostatic Diseases(2021)10.1038/s41391-021-00460-y

N/A

0DataRank · unranked

4 citations

Wen-Chi Foo, Tyler A. Allen, Jason A. Somarelli, Kathryn E. Ware, Santosh Gupta +19 more

A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer

Frontiers in Molecular Biosciences(2023)10.3389/fmolb.2023.1104505

N/A

0DataRank · unranked

9 citations

Beatrice C. Thomas, Pelumi Olawuni, Maya U. Sheth, Nathan Hawkey, M. Yeshwanth +7 more